Congress Can Improve FDA’s Approval Process

Partisanship has dominated this Congress, with Democrats aggressively pushing their agenda in the face of stiff GOP opposition. But members on both sides have a golden opportunity to demonstrate they can still deliver for the American people when they consider the reauthorization of the Food and Drug Administration (FDA) drug and device user fee programs.